Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against The Chemours Company and Encourages Investors with Losses to Contact the Firm

CC

LOS ANGELES, CA / ACCESSWIRE / March 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company ("Chemours" or "the Company") (NYSE:CC) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Chemours is the subject of a Wall Street Journal report published on February 29, 2024. According to the report, "Chemours late Wednesday said President and Chief Executive Mark Newman, Chief Financial Officer Jonathan Lock and Principal Accounting Officer Camela Wisel are on leave pending completion of the review, which is being overseen by the board's audit committee with the assistance of independent outside counsel." The Journal explains, "The Wilmington, Del., company said it is looking into the processes for reviewing reports made to its ethics hotline, practices for managing working capital, including the related impact on metrics within its incentive plans, and certain non-GAAP metrics included in filings made with the Securities and Exchange Commission or otherwise publicly released." Based on this news, shares of Chemours fell by almost 34% in pre-market trading on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm



View the original press release on accesswire.com

Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today